Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme.

MLA

Regueiro, Miguel, et al. “Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme.” Journal of Crohn’s & Colitis, vol. 18, no. 10, Oct. 2024, pp. 1596–605. EBSCOhost, https://doi.org/10.1093/ecco-jcc/jjae060.

APA

Regueiro, M., Siegmund, B., Yarur, A. J., Steinwurz, F., Gecse, K. B., Goetsch, M., Bhattacharjee, A., Wu, J., Green, J., McDonnell, A., Crosby, C., Lazin, K., Branquinho, D., Modesto, I., & Abreu, M. T. (2024). Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme. Journal of Crohn’s & Colitis, 18(10), 1596–1605. https://doi.org/10.1093/ecco-jcc/jjae060

Chicago

Regueiro, Miguel, Britta Siegmund, Andres J Yarur, Flavio Steinwurz, Krisztina B Gecse, Martina Goetsch, Abhishek Bhattacharjee, et al. 2024. “Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme.” Journal of Crohn’s & Colitis 18 (10): 1596–1605. doi:10.1093/ecco-jcc/jjae060.